Worldwide: Food, Drugs, Healthcare, Life Sciences

The idea seems brilliantly simple: Create a digital health marketplace to connect doctors and patients online and streamline access to care.

Last week, Congress enacted the Consolidated Appropriations Act of 2026. This legislation narrows the scope of the statutory protection for drugs for rare diseases and conditions under the Orphan Drug Act, 21 U.S. Code § 360cc.

Last week, on February 3, 2026, Congress passed the Consolidated Appropriations Act ("the Act"), providing generic drug manufacturers much-needed clarity as to when inactive ingredients in an ANDA are qualitatively and quantitatively ("Q1/Q2") the same as those in the reference listed drug ("RLD").